S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS - Nizar J Bahlis; Katja Weisel; Maria-Victoria Mateos; Hartmut Goldschmidt; Tom Martin; Daniel Morillo; Donna Reece; Paula Rodríguez-Otero; Manisha Bhutani; Anita D’souza; Albert Oriol; Laura Rosiñol Dachs; et al. (HemaSphere, 2023)